PharmGKB:  The Pharmacogenetics and Pharmacogenomics Knowledge Base
Search PharmGKB:?
 

Important Variant Information for P2RY12

Submitted by: Katrin Sangkuhl (PharmGKB)
Reviewed by: under review
Submitted date: Feb 28, 2008

There is One Important Variant for P2RY12.

  1. P2RY12:744T>C


1. P2RY12:744T>C

Gene HGNC Name: P2RY12
Variant Summary: The antithrombotic effect of clopidogrel and the ADP-induced platelet response are considerably variable. Therefore the P2RY12 gene was screened for possible variants. Two functional haplotypes were identified. These haplotypes can be differentiated by any of four tagging SNPs in absolute linkage disequilibrium. One of these markers is i-T744C, which is used in several studies for genotyping the participants. This variant is located 744 nt after the 5' intron start site and consists of a T-to-C transition [12912815].
The T744C polymorphism showed no influence on clopidogrel response in patients with non ST elevation acute coronary syndrome [17337040]. This SNP was used to tag the H2 haplotype to show association with peripherial arterial disease [14662702] and coronary artery disease [17803810].
Key PubMed IDs: 12912815, 14662702, 17803810
Genomic Variant & GenBank ID: 57553587 C>T on NT_005612
mRNA Variant & GenBank ID: N/A
Protein Variant & GenBank ID: N/A
dbSNP rs#: rs2046934
GoldenPath Position: chr3:152540332 (hg18)
Key Drugs/Substrates: clopidogrel
Key Phenotypes/Diseases: Cardiovascular Diseases
Phenotype Data Sets: N/A
Key Haplotypes: P2RY12:H2 haplotype
The PGRN is financially supported by grants from NIGMS, NHLBI, NHGRI, NIEHS, NCI, and NLM within the NIH, HHS. PharmGKB is managed at Stanford University. This work is supported by the NIH/NIGMS Pharmacogenetics Research Network and Database (U01GM61374). ©2001-2008 PharmGKB.